The promise of genetically engineered mice for cancer prevention studies.
Sophisticated genetic technologies have led to the development of mouse models of human cancers that recapitulate important features of human oncogenesis. Many of these genetically engineered mouse models promise to be very relevant and relatively rapid systems for determining the efficacy of chemopreventive agents and their mechanisms of action. The validation of such models for chemoprevention will help the selection of appropriate agents for large-scale clinical trials and allow the testing of combination therapies.
Green
Jeffrey E
JE
Transgenic Oncogenesis Group, Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, Besthesda, MD 20892, USA. jegreen@mail.nih.gov
Hudson
Tamaro
T
D000818:Animals; D030801:Animals, Genetically Modified; D000970:Antineoplastic Agents / Q000494:pharmacology; D018890:Chemoprevention; D003110:Colonic Neoplasms / Q000235:genetics / Q000662:veterinary; D004195:Disease Models, Animal; D006801:Humans; D008325:Mammary Neoplasms, Experimental / Q000235:genetics; D051379:Mice; D009369:Neoplasms / Q000235:genetics* / Q000517:prevention & control*
D000970:Antineoplastic Agents